164 related articles for article (PubMed ID: 29803986)
1. The CardiAMP Heart Failure trial: A randomized controlled pivotal trial of high-dose autologous bone marrow mononuclear cells using the CardiAMP cell therapy system in patients with post-myocardial infarction heart failure: Trial rationale and study design.
Raval AN; Cook TD; Duckers HJ; Johnston PV; Traverse JH; Abraham WT; Altman PA; Pepine CJ
Am Heart J; 2018 Jul; 201():141-148. PubMed ID: 29803986
[TBL] [Abstract][Full Text] [Related]
2. Point of care, bone marrow mononuclear cell therapy in ischemic heart failure patients personalized for cell potency: 12-month feasibility results from CardiAMP heart failure roll-in cohort.
Raval AN; Johnston PV; Duckers HJ; Cook TD; Traverse JH; Altman PA; Dhingra R; Hematti P; Borrello I; Anderson RD; Pepine CJ
Int J Cardiol; 2021 Mar; 326():131-138. PubMed ID: 33091520
[TBL] [Abstract][Full Text] [Related]
3. Autologous bone marrow mononuclear cell transplantation in ischemic heart failure: a prospective, controlled, randomized, double-blind study of cell transplantation combined with coronary bypass.
Pätilä T; Lehtinen M; Vento A; Schildt J; Sinisalo J; Laine M; Hämmäinen P; Nihtinen A; Alitalo R; Nikkinen P; Ahonen A; Holmström M; Lauerma K; Pöyhiä R; Kupari M; Kankuri E; Harjula A
J Heart Lung Transplant; 2014 Jun; 33(6):567-74. PubMed ID: 24656645
[TBL] [Abstract][Full Text] [Related]
4. Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial).
Mathiasen AB; Jørgensen E; Qayyum AA; Haack-Sørensen M; Ekblond A; Kastrup J
Am Heart J; 2012 Sep; 164(3):285-91. PubMed ID: 22980293
[TBL] [Abstract][Full Text] [Related]
5. Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial.
Assmus B; Walter DH; Seeger FH; Leistner DM; Steiner J; Ziegler I; Lutz A; Khaled W; Klotsche J; Tonn T; Dimmeler S; Zeiher AM
JAMA; 2013 Apr; 309(15):1622-31. PubMed ID: 23592107
[TBL] [Abstract][Full Text] [Related]
6. Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy.
Trachtenberg B; Velazquez DL; Williams AR; McNiece I; Fishman J; Nguyen K; Rouy D; Altman P; Schwarz R; Mendizabal A; Oskouei B; Byrnes J; Soto V; Tracy M; Zambrano JP; Heldman AW; Hare JM
Am Heart J; 2011 Mar; 161(3):487-93. PubMed ID: 21392602
[TBL] [Abstract][Full Text] [Related]
7. LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction.
Traverse JH; Henry TD; Vaughan DE; Ellis SG; Pepine CJ; Willerson JT; Zhao DX; Simpson LM; Penn MS; Byrne BJ; Perin EC; Gee AP; Hatzopoulos AK; McKenna DH; Forder JR; Taylor DA; Cogle CR; Baraniuk S; Olson RE; Jorgenson BC; Sayre SL; Vojvodic RW; Gordon DJ; Skarlatos SI; Moyè LA; Simari RD;
Tex Heart Inst J; 2010; 37(4):412-20. PubMed ID: 20844613
[TBL] [Abstract][Full Text] [Related]
8. Effect of intracoronary transplantation of autologous bone marrow-derived mononuclear cells on outcomes of patients with refractory chronic heart failure secondary to ischemic cardiomyopathy.
Gao LR; Wang ZG; Zhu ZM; Fei YX; He S; Tian HT; Zhang NK; Chen Y; Xu HT; Yang Y
Am J Cardiol; 2006 Sep; 98(5):597-602. PubMed ID: 16923443
[TBL] [Abstract][Full Text] [Related]
9. Endomyocardial implantation of autologous bone marrow mononuclear cells in advanced ischemic heart failure: a randomized placebo-controlled trial (END-HF).
Santoso T; Siu CW; Irawan C; Chan WS; Alwi I; Yiu KH; Aziz A; Kwong YL; Tse HF
J Cardiovasc Transl Res; 2014 Aug; 7(6):545-52. PubMed ID: 25079593
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous, transendocardial injection of bone marrow-derived mononuclear cells in heart failure patients following acute ST-elevation myocardial infarction: ALSTER-Stem Cell trial.
Heeger CH; Jaquet K; Thiele H; Zulkarnaen Y; Cuneo A; Haller D; Kivelitz D; Schmidt T; Krause K; Metzner A; Schneider C; Kuck KH; Bergmann MW
EuroIntervention; 2012 Oct; 8(6):732-42. PubMed ID: 23086792
[TBL] [Abstract][Full Text] [Related]
11. Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial.
Perin EC; Willerson JT; Pepine CJ; Henry TD; Ellis SG; Zhao DX; Silva GV; Lai D; Thomas JD; Kronenberg MW; Martin AD; Anderson RD; Traverse JH; Penn MS; Anwaruddin S; Hatzopoulos AK; Gee AP; Taylor DA; Cogle CR; Smith D; Westbrook L; Chen J; Handberg E; Olson RE; Geither C; Bowman S; Francescon J; Baraniuk S; Piller LB; Simpson LM; Loghin C; Aguilar D; Richman S; Zierold C; Bettencourt J; Sayre SL; Vojvodic RW; Skarlatos SI; Gordon DJ; Ebert RF; Kwak M; Moyé LA; Simari RD;
JAMA; 2012 Apr; 307(16):1717-26. PubMed ID: 22447880
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Outcome of Intra-Myocardial Injection of Autologous Bone Marrow Mononuclear Cells Combined with Isolated Coronary Artery Bypass Grafting for Patients with Chronic Ischemic Heart Failure.
Wang R; Zhang L; Wang Y; Gong Z; Xiao C; Wu Y; Ren C; Cheng N; Gao C
Heart Surg Forum; 2016 Jun; 19(3):E131-8. PubMed ID: 27355149
[TBL] [Abstract][Full Text] [Related]
13. Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival.
Assmus B; Leistner DM; Schächinger V; Erbs S; Elsässer A; Haberbosch W; Hambrecht R; Sedding D; Yu J; Corti R; Mathey DG; Barth C; Mayer-Wehrstein C; Burck I; Sueselbeck T; Dill T; Hamm CW; Tonn T; Dimmeler S; Zeiher AM;
Eur Heart J; 2014 May; 35(19):1275-83. PubMed ID: 24569031
[TBL] [Abstract][Full Text] [Related]
14. A pilot trial of autologous bone marrow mononuclear cell transplantation through grafting artery: a sub-study focused on segmental left ventricular function recovery and scar reduction.
Lu M; Liu S; Zheng Z; Yin G; Song L; Chen H; Chen X; Chen Q; Jiang S; Tian L; He Z; Hu S; Zhao S
Int J Cardiol; 2013 Oct; 168(3):2221-7. PubMed ID: 23478196
[TBL] [Abstract][Full Text] [Related]
15. Rationale and design of a prospective, randomised study of retrograde application of bone marrow aspirate concentrate (BMAC) through coronary sinus in patients with congestive heart failure of ischemic etiology (the RETRO study).
Pleva L; Kukla P; Vítková K; Procházka V
BMC Cardiovasc Disord; 2019 Jan; 19(1):32. PubMed ID: 30704414
[TBL] [Abstract][Full Text] [Related]
16. Efficiency of intramyocardial injections of autologous bone marrow mononuclear cells in patients with ischemic heart failure: a randomized study.
Pokushalov E; Romanov A; Chernyavsky A; Larionov P; Terekhov I; Artyomenko S; Poveshenko O; Kliver E; Shirokova N; Karaskov A; Dib N
J Cardiovasc Transl Res; 2010 Apr; 3(2):160-8. PubMed ID: 20560030
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of intramyocardial injection of autologous bone marrow-derived mononuclear cells in patients with severe angina pectoris and stress-induced myocardial ischemia.
Beeres SL; Bax JJ; Kaandorp TA; Zeppenfeld K; Lamb HJ; Dibbets-Schneider P; Stokkel MP; Fibbe WE; de Roos A; van der Wall EE; Schalij MJ; Atsma DE
Am J Cardiol; 2006 May; 97(9):1326-31. PubMed ID: 16635605
[TBL] [Abstract][Full Text] [Related]
18. Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.
Heldman AW; DiFede DL; Fishman JE; Zambrano JP; Trachtenberg BH; Karantalis V; Mushtaq M; Williams AR; Suncion VY; McNiece IK; Ghersin E; Soto V; Lopera G; Miki R; Willens H; Hendel R; Mitrani R; Pattany P; Feigenbaum G; Oskouei B; Byrnes J; Lowery MH; Sierra J; Pujol MV; Delgado C; Gonzalez PJ; Rodriguez JE; Bagno LL; Rouy D; Altman P; Foo CW; da Silva J; Anderson E; Schwarz R; Mendizabal A; Hare JM
JAMA; 2014 Jan; 311(1):62-73. PubMed ID: 24247587
[TBL] [Abstract][Full Text] [Related]
19. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction.
Lunde K; Solheim S; Aakhus S; Arnesen H; Abdelnoor M; Egeland T; Endresen K; Ilebekk A; Mangschau A; Fjeld JG; Smith HJ; Taraldsrud E; Grøgaard HK; Bjørnerheim R; Brekke M; Müller C; Hopp E; Ragnarsson A; Brinchmann JE; Forfang K
N Engl J Med; 2006 Sep; 355(12):1199-209. PubMed ID: 16990383
[TBL] [Abstract][Full Text] [Related]
20. REVIVE Trial: Retrograde Delivery of Autologous Bone Marrow in Patients With Heart Failure.
Patel AN; Mittal S; Turan G; Winters AA; Henry TD; Ince H; Trehan N
Stem Cells Transl Med; 2015 Sep; 4(9):1021-7. PubMed ID: 26217065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
